Dementia medications in palliative care #174.
Morrison
Laura J
LJ
Baylor College of Medicine, Houston, TX 77584, USA. lmorriso@bcm.tmc.edu
Liao
Solomon
S
D000978:Antiparkinson Agents / Q000627:therapeutic use; D002800:Cholinesterase Inhibitors / Q000627:therapeutic use*; D003704:Dementia / Q000150:complications / Q000188:drug therapy* / Q000503:physiopathology; D018450:Disease Progression; D000077265:Donepezil; D005702:Galantamine / Q000627:therapeutic use; D006801:Humans; D007189:Indans / Q000627:therapeutic use; D008559:Memantine / Q000627:therapeutic use; D018696:Neuroprotective Agents / Q000627:therapeutic use; D018697:Nootropic Agents / Q000627:therapeutic use; D010166:Palliative Care / Q000379:methods*; D048448:Phenylcarbamates / Q000627:therapeutic use; D010880:Piperidines / Q000627:therapeutic use; D011379:Prognosis; D016194:Receptors, N-Methyl-D-Aspartate / Q000037:antagonists & inhibitors*; D000068836:Rivastigmine
D000978:Antiparkinson Agents; D002800:Cholinesterase Inhibitors; D007189:Indans; D018696:Neuroprotective Agents; D018697:Nootropic Agents; D048448:Phenylcarbamates; D010880:Piperidines; D016194:Receptors, N-Methyl-D-Aspartate; D005702:Galantamine; D000077265:Donepezil; D000068836:Rivastigmine; D008559:Memantine